Neurology

Hematologic Malignancies

Questions discussed in this category

How do you manage IgM related peripheral neuropathy?

Do you utilize rituximab or any other specific management strategies?

How would you approach grade 2 neurologic toxicity in a patient on daratumumab, dexamethasone, and lenalidomide for relapsed multiple myeloma?

Regimen currently 25 mg lenalidomide D1-21 of D28 day cycles, Daratumumab 16 mg/kg every 2 weeks.

1 Answer available

When patients develop headaches from luspatercept, do they tend to improve over time?

1 Answer available

Do you typically see peripheral neuropathy in patients with castleman syndrome?

2 Answers available

Do you recommend work up for POEMS and/or amyloidosis for IgM monoclonal gammopathies associated with neuropathy?

Can you expand on this by sharing exactly what this routine workup should include? What additional tests outside of evaluating for POEMS and amyloidos...

2 Answers available

Papers discussed in this category

Mayo Clin Proc,

Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.

Neurol Sci, 2021 Sep 16

Paraproteinemia and neuropathy.

Pediatr Blood Cancer, 2021 Oct

Idiopathic multicentric Castleman disease with TAFRO clinical subtype responsive to IL-6/JAK inhibition: A pediatric case series.

Neurology

Hematologic Malignancies

Questions discussed in this category

Papers discussed in this category

Related Topics in Neurology